GlucoTrack Publishes Pro Forma Combined Financial Statements Following Lokahi Therapeutics Merger
Bitget2026/10/28 20:19- GlucoTrack published pro forma financial statements reflecting its July 14, 2026, merger with Lokahi Therapeutics.
- Net loss for the six months ended June 30, 2026, reached $19.7 million, including $13.56 million in operating expenses.
- Bridge Financing added $3.45 million in expenses, including interest expense and a loss on issuance of convertible notes.
- The 2025 net loss totaled $28.14 million, with no revenue.
- As of June 30, 2026, total assets reached $54.46 million, including $10.62 million in cash and cash equivalents.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
